AEON - AEON Biopharma, Inc.
1.06
0.030 2.830%
Share volume: 39,043
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.03
0.03%
Summary score
45%
Profitability
53%
Dept financing
43%
Liquidity
34%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2021 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-170.71%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
1084.86%
Debt ratio change over timeo
0%
Current Ratio
0.38%
Quick Ratio
0%
Cash Position Ratio
0.24%
Short-term ratios 30-Sep-2024 - 30-Sep-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
63.24%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
506.3%
Debt ratio change over timeo
0%
Current Ratio
0.81%
Quick Ratio
0%
Cash Position Ratio
0.64%
Last quarter ratios 30-Sep-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
327.52%
Debt ratio change over time
0%
Current Ratio
0.9%
Quick Ratio
0%
Cash Position Ratio
0.72%
Performance ratios (change over 4 years) 30-Sep-2021 - 30-Sep-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AEON | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 13.23% | 9.84% | 26.17% |
| Return on assets | -170.71% | 4.59% | 3.2% | 1.81% |
| Return on sales | 0% | 30.04% | 25.15% | 24.65% |
| Return on invested capital | 0% | 8.51% | 10.28% | 4.83% |
| Profitability | 0% | 83% | 73% | 67% |
| Total debt ratio | 1084.86% | 80.7% | 59.39% | 93.28% |
| Debt ratio change over time | 0% | -16.59% | -73.52% | 21.11% |
| Dept financing | 25% | 2% | 1% | 27% |
| Current Ratio | 0.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 0.64% | 0.14% | 0.46% | 0.15% |
| Liquididy | 19% | 57% | 75% | 49% |
| Short-term ratios | AEON | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 63.24% | 5.82% | 4.08% | 0.78% |
| Return on sales | 0% | 38.27% | 25.36% | 15.48% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 75% | 27% | 18% | 10% |
| Total debt ratio | 506.3% | 81.38% | 59.57% | 99.65% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 4% | 3% | 5% |
| Current Ratio | 0.81% | 1.34% | 1.11% | 0.72% |
| Quick Ratio | 0% | 1.05% | 0.86% | 0.6% |
| Cash Position Ratio | 0.64% | 0.14% | 0.46% | 0.15% |
| Liquididy | 40% | 55% | 59% | 34% |